TRxADE HEALTH, INC. Files 8-K Report
Ticker: SCNX · Form: 8-K · Filed: Jul 9, 2024 · CIK: 1382574
| Field | Detail |
|---|---|
| Company | Trxade Health, Inc (SCNX) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001, $1.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory
Related Tickers: TRx
TL;DR
TRxADE HEALTH filed a routine 8-K, no major news.
AI Summary
On July 8, 2024, TRxADE HEALTH, INC. filed an 8-K report detailing "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.
Why It Matters
This filing indicates TRxADE HEALTH, INC. is fulfilling its regulatory reporting obligations with the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard SEC disclosure and does not report any new material events or financial changes.
Key Players & Entities
- TRxADE HEALTH, INC. (company) — Registrant
- July 8, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39199 (commission_file_number) — SEC File Number
- 46-3673928 (irs_number) — I.R.S. Employer Identification No.
- Tampa, Florida (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report "Other Events" and "Financial Statements and Exhibits" as of July 8, 2024.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is July 8, 2024.
In which state is TRxADE HEALTH, INC. incorporated?
TRxADE HEALTH, INC. is incorporated in Delaware.
What is the SEC file number for TRxADE HEALTH, INC.?
The SEC file number for TRxADE HEALTH, INC. is 001-39199.
Where are the principal executive offices of TRxADE HEALTH, INC. located?
The principal executive offices of TRxADE HEALTH, INC. are located in Tampa, Florida.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 9.3 · Accepted 2024-07-09 08:05:39
Key Financial Figures
- $0.00001 — ch registered Common stock, par value $0.00001 per share MEDS The Nasdaq Stock Mar
- $1.50 — claration of a special cash dividend of $1.50 per share of common stock, payable to s
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 8KB
- ex99-1_001.jpg (GRAPHIC) — 19KB
- 0001493152-24-026571.txt ( ) — 248KB
- meds-20240708.xsd (EX-101.SCH) — 3KB
- meds-20240708_lab.xml (EX-101.LAB) — 33KB
- meds-20240708_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRxADE HEALTH, INC. By: /s/ Surendra Ajjarapu Surendra Ajjarapu Chief Executive Officer Date: July 9, 2024